Article
Genetic Mutations of Pancreatic Cancer and Genetically Engineered Mouse Models
24 Dec 2021
Abstract excerpt
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy, and the seventh leading cause of cancer-related deaths worldwide. An improved understanding of tumor biology and novel therapeutic discoveries are needed to improve overall survival. Recent multi-gene analysis approaches such as next-generation sequencing have provided useful information on the molecular characterization of pancreatic...
Topics
Join the communities discussing this publication.
